ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Lung

March 24, 2020
A succinct comment with a wealth of up-to-date references vis-a-vis the SARS-CoV-2 pandemic.
March 23, 2020
This case report suggests that recurrent right pleural effusions could be a side effect of hepatic artery infusion pump chemotherapy in the treatment of metastatic colorectal cancer.
March 22, 2020
Leanne Harling, Doug Mathisen, and Erino Rendina share and debate their approaches to staging, adjuvant therapy, persistent disease, and surgical removal of the primary tumor.
March 20, 2020
Interesting input from a Stanford expert on the hottest topic on the planet at the moment.
March 18, 2020
The authors describe a thoughtful process for resource utilization in the setting of competing needs that optimizes survival for a popultion. Examples of existing guidelines are provided.
March 18, 2020
The authors examined the SEER database to assess racial disparities in use of PET for lung cancer staging 2007-2015 and subsequent one-year survival. Blacks  (OR 0.54) and Hispanics (OR 0.72) were less likely to undergo PET compared to non-Hispanic whites. Use of PET was associated with improved survival (HR 0.61).  
March 13, 2020
This article analyzes the outcome of video-assisted thoracoscopic lung resections performed at night compared to daytime operations. Nighttime operations carried a higher risk of intraoperative complications. The authors conclude surgeons should avoid nighttime operations whenever possible.
February 17, 2020
This video demonstrates a trainee-led open resection of four pulmonary nodules using the LEONARDO® Dual Wave 200W laser system.
February 13, 2020
Richard Booton of the Manchester University NHS Foundation in the United Kingdom presents a discussion on lung health checks and lung cancer screening.
February 8, 2020
The newest version of the ASCO guidelines for lung cancer surveillance after curative lung cancer therapy is presented. The overall quality of supportive evidence is low, and the strength of recommendations is moderate. CT is recommended as the optimal imaging modality.

Pages